People
Liisa Selin, MD, PhD, Professor, Dept of Pathology, University of Massachusetts Chan Medical School, is a fully-trained infectious disease specialist who has conducted more than 30 years of research focused on chronic diseases, including ME/CFS, Epstein-Barr virus, Influenza A and other viral species, and, most recently, Long COVID. Dr. Selin has published many articles on the role of T-cells in response to viral infections. Specifically, she conducted research that initially identified and focused on the phenomenon of heterologous immunity, whereby memory T cell responses to pathogens can influence the outcome to subsequent infection with unrelated pathogens. To date, Dr. Selin has received 12 NIH grant awards, totaling $20 million, funded to UMass Chan. Five of those grant awards were part of large, highly-prestigious collaborative research projects, which altogether brought $78 million to UMass Chan. Dr. Selin is an unpaid consultant to Inspiritol, Inc., a virtual pharmaceutical start-up. Dr. Selin has ME/CFS.
Anna Gil, PhD, Instructor of Department of Pathology at University of Massachusetts Chan Medical School, has worked closely with Dr. Selin for the past 14 years. Her focus is on viral immunopathogenesis and she has done seminal work in the role of T-cell receptor repertoire in disease outcome during viral infections. More recently, she has focused on the role of T cells in the immunopathogenesis of chronic conditions, such as multiple sclerosis, ME/CFS and Long COVID.
Nuray Aslan, MS, PhD, viral immunologist and postdoctoral fellow with the Selin Lab.
Andrea Joliat, BA, M.Photog. volunteer with the Selin Lab and a loving mother of a son with ME/CFS.
Temsalet Molla, BS, Selin Lab Technician.
Rivka Solomon, MS, consultant, ME/CFS and Long COVID Patient Representative to the Selin Lab, also a Patient Rep for two PLRC-funded research projects: the Selin Lab's T cell research and also the HiFiBiO-Selin Lab collaboration on single cell immune profiling.
Collaborators
Cynthia Adinig, ME/CFS and Long COVID advocate, Health Equity Advocate & Equity Policy Advisor, and CEO of BIPOC Equity Agency.
Megan L. Fitzgerald, PhD (Neuroscience/Neurology), Researcher and Patient Rep, lead of the Patient-Led Research Collaborative's reinfections study, and Patient Rep for two PLRC-funded research projects: the Selin Lab's T cell research and the HiFiBiO-Selin Lab collaboration on single cell immune profiling.
Dario Ghersi, MD, PhD, Associate Professor, School of Interdisciplinary Informatics, Univ of Nebraska at Omaha, specializing in T cell receptor modeling and large scale data analysis.
Christopher Hemond, MD, neurologist with specialty in multiple sclerosis, Department of Neurology, University of Massachusetts Chan Medical School.
Mady Hornig, MA, MD, President, CORe Community, Inc (COVID Recovery through Community).
Carolina Ionete, MD, PhD, Professor of Neurology, and Director of the Neuroimmunology/MS Division and Multiple Sclerosis Center, University of Massachusetts Chan Medical School, Department of Neurology.
Nancy Klimas, MD, Director of Nova Southeastern University's Institute for Neuro-Immune Medicine.
Roshan Kumar, PhD, Executive Director, Head of Research, HiFiBiO Therapeutics, a clinical stage US biotech with a global footprint that is pioneering a unique high-resolution translational platform (DIS®) to enhance the probability of success for therapies. HiFIBIO is the recipient of a grant from The Patient-Led Research Collaborative to research Long COVID and ME/CFS in collaboration with UMass Chan Medical School.
Michal "Mikki" Caspi Tal, PhD, Principal Scientist, Department of Biological Engineering, Tal Research Group, Massachusetts Institute of Technology. Associate Scientific Director, MIT Center for Gynepathology Research.
Beth Pollack, Research Scientist, Department of Biological Engineering, Tal Research Group, Massachusetts Institute of Technology.
